NCT05146635 2022-01-11Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled TrialMansoura UniversityPhase NA Unknown110 enrolled
NCT01094964 2013-08-12Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder CancerNational Cancer Institute (NCI)Phase 3 Unknown242 enrolled